{
    "code": "01026999",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01026999",
    "time": "2019-04-19 03:41:58",
    "許可證字號": "衛署藥製字第026999號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/03\/26",
    "發證日期": "72\/03\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102699908",
    "中文品名": "寶利康散",
    "英文品名": "POLYASE POWDER",
    "適應症": "幫助消化",
    "劑型": "140散劑",
    "包裝": "瓶裝 罐裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "07須經醫師指示使用",
    "主成分略述": [
        "NEWLASE,DIASTASEBIO-,LIPASE"
    ],
    "限制項目": "01國　產 09委託製造",
    "申請商名稱": "620117F846  秉新藥業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "620102P136  躍欣生技醫藥股份有限公司",
        "製造廠廠址": "新竹縣湖口鄉光復路10號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4400002700",
            "成分名稱": "NEWLASE",
            "含量描述": "20",
            "含量": "20.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "5616000780",
            "成分名稱": "DIASTASE BIO-",
            "含量描述": "(1000) 60",
            "含量": "",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "5616000900",
            "成分名稱": "LIPASE",
            "含量描述": "(AP6) 10",
            "含量": "",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010269990001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01026999&Seq=001&Type=9"
        }
    ]
}